Oric Pharmaceuticals (ORIC) Net Cash Flow (2019 - 2026)

Oric Pharmaceuticals' Net Cash Flow history runs 8 years deep, the most recent figure standing at $10.7 million for Q1 2026.

• Quarterly Net Cash Flow rose 206.5% year-over-year to $10.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.1 million (up 200.51% YoY) and the FY2025 annual result came in at -$13.7 million, down 138.14% from the prior year.
• Net Cash Flow was $10.7 million for Q1 2026 at Oric Pharmaceuticals, up from -$4.0 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $44.7 million in Q2 2023 and bottomed at -$113.4 million in Q1 2022.
• A 5-year average of -$10.0 million and a median of -$5.6 million in 2024 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2022 — Net Cash Flow sank 540.04% — and 2024, when it surged 631.74%.
• Oric Pharmaceuticals' Net Cash Flow stood at $37.8 million in 2022, then slumped by 107.56% to -$2.9 million in 2023, then jumped by 631.74% to $15.2 million in 2024, then plunged by 126.35% to -$4.0 million in 2025, then soared by 368.24% to $10.7 million in 2026.
• Business Quant data shows ORIC's Net Cash Flow at $10.7 million in Q1 2026, -$4.0 million in Q4 2025, and -$26.2 million in Q3 2025.